170 related articles for article (PubMed ID: 1421423)
1. IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.
Brünner N; Moser C; Clarke R; Cullen K
Breast Cancer Res Treat; 1992; 22(1):39-45. PubMed ID: 1421423
[TBL] [Abstract][Full Text] [Related]
2. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
3. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).
Brünner N; Yee D; Kern FG; Spang-Thomsen M; Lippman ME; Cullen KJ
Eur J Cancer; 1993; 29A(4):562-9. PubMed ID: 8435211
[TBL] [Abstract][Full Text] [Related]
4. The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer.
Brunner N; Spang-Thomsen M; Cullen K
Breast Cancer Res Treat; 1996; 39(1):87-92. PubMed ID: 8738608
[TBL] [Abstract][Full Text] [Related]
5. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
Daly RJ; Harris WH; Wang DY; Darbre PD
Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
[TBL] [Abstract][Full Text] [Related]
6. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
Fox EM; Miller TW; Balko JM; Kuba MG; Sánchez V; Smith RA; Liu S; González-Angulo AM; Mills GB; Ye F; Shyr Y; Manning HC; Buck E; Arteaga CL
Cancer Res; 2011 Nov; 71(21):6773-84. PubMed ID: 21908557
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.
Kahán Z; Varga JL; Schally AV; Rékási Z; Armatis P; Chatzistamou L; Czömpöly T; Halmos G
Breast Cancer Res Treat; 2000 Mar; 60(1):71-9. PubMed ID: 10845811
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
Kasid A; Lippman ME
J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
11. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M
Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082
[TBL] [Abstract][Full Text] [Related]
12. Influence of hormones on tumor growth, cell kinetics, estrogen receptor and insulin-like growth factor-I-related protein of human breast cancer (MCF-7) cells transplanted in nude mice.
Noguchi M; Thomas M; Koyasaki N; Ohta N; Taniya T; Kitagawa H; Miyazaki I; Mizukami Y
Mol Cell Endocrinol; 1993 Mar; 92(1):69-76. PubMed ID: 8472869
[TBL] [Abstract][Full Text] [Related]
13. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
Jordan VC; Gottardis MM; Robinson SP; Friedl A
J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
17. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
18. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.
Osborne CK; Ross CR; Coronado EB; Fuqua SA; Kitten LJ
Breast Cancer Res Treat; 1988 Jul; 11(3):211-9. PubMed ID: 3167228
[TBL] [Abstract][Full Text] [Related]
19. Regulation of estrogen receptor expression in breast cancer.
Martin MB; Saceda M; Lindsey RK
Adv Exp Med Biol; 1993; 330():143-53. PubMed ID: 8368130
[TBL] [Abstract][Full Text] [Related]
20. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
